title: Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation.
authors.affiliation: Department of Hematology (Tseng), University of Toronto, Toronto, Ont.; Departments of Pathology and Molecular Medicine (Crowther) and of Oncology (Hillis), McMaster University, Hamilton, Ont.
authors.forename: Eric
authors.initials: E
authors.lastname: Tseng
authors.affiliation: Department of Hematology (Tseng), University of Toronto, Toronto, Ont.; Departments of Pathology and Molecular Medicine (Crowther) and of Oncology (Hillis), McMaster University, Hamilton, Ont.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Crowther
authors.affiliation: Department of Hematology (Tseng), University of Toronto, Toronto, Ont.; Departments of Pathology and Molecular Medicine (Crowther) and of Oncology (Hillis), McMaster University, Hamilton, Ont. hillisc@mcmaster.ca.
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Hillis
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D019990:Perioperative Care / Q000379:methods*; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D011470:Prostatic Hyperplasia / Q000150:complications / Q000601:surgery; D018570:Risk Assessment; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*; D020728:Transurethral Resection of Prostate; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin